A Century-Old Innovator Leading Global Healthcare
Founded in 1888 by Dr. Wallace C. Abbott, Abbott Laboratories has evolved into a global healthcare leader, delivering innovative solutions across diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Headquartered in Abbott Park, Illinois, the company operates in over 160 countries, with approximately 70% of its revenue generated from international markets.
Diverse Portfolio Driving Health Innovation
Abbott’s diversified portfolio includes:
- Diagnostics: Advanced testing solutions for infectious diseases, cancer, and cardiac conditions.
- Medical Devices: Products for cardiovascular care, diabetes management, neuromodulation, and structural heart interventions.
- Nutrition: Science-based nutritional products for infants, children, and adults, including brands like Ensure® and Pedialyte®.
- Branded Generic Pharmaceuticals: Affordable medications tailored to the needs of emerging markets.
Recent Innovations and Developments
In 2025, Abbott introduced several groundbreaking technologies:
- A next-generation delivery system to streamline electrode placement during dorsal root ganglion stimulator implantations.
- The Volt™ Pulsed Field Ablation System received CE Mark approval to treat patients with abnormal heart rhythms.
- New data reinforced the benefits of Abbott’s TriClip™ device for individuals with leaky tricuspid heart valves.
Leadership and Vision
Under the leadership of CEO Robert B. Ford since 2020, Abbott has emphasized agility and innovation. Ford’s tenure has been marked by a focus on rapid product development, exemplified by the swift rollout of the BinaxNOW™ COVID-19 at-home test.
Commitment to Sustainability and Inclusion
Abbott is dedicated to sustainability, aiming to deliver long-term impact through responsible business practices. The company also prioritizes diversity and inclusion, with initiatives to promote women in STEM fields and leadership development programs.
Financial Performance and Outlook
Abbott continues to demonstrate strong financial performance, with consistent dividend increases for over five decades. The company’s strategic investments in innovation and global expansion position it for sustained growth in the evolving healthcare landscape.
